Literature DB >> 12888381

Multimodal CME for surgeons and pathologists improves colon cancer staging.

Andrew J Smith1, Calvin H L Law, Mahmoud A Khalifa, Eugene T K Hsieh, Sherif S Hanna, Frances C Wright, Peeter A Poldre.   

Abstract

BACKGROUND: Optimal treatment of localized colorectal cancer (CRC) depends on accurate retrieval and assessment of lymph nodes (LN) in the resected specimen.
METHODS: Formal CE, informal opinion leadership and reinforcing strategies aimed at pathologists and surgeons to improve LN assessment were implemented.
RESULTS: In the pre-intervention period a median of 8 lymph nodes were assessed in making a designation of Stage II CRC (n = 115). Thirty months later (post-intervention period) the median number of LN reported in Stage II CRC increased to 18 (n = 41), p < 0.001.
CONCLUSION: A durable improvement in staging was realized through a multipronged change initiative aimed at both surgeons and pathologists.

Entities:  

Mesh:

Year:  2003        PMID: 12888381     DOI: 10.1207/S15430154JCE1802_09

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  8 in total

1.  Effectiveness of continuing medical education in increasing colorectal cancer screening knowledge among Vietnamese American physicians.

Authors:  Bang H Nguyen; Jane T Pham; Rilene A Chew; Stephen J McPhee; Susan L Stewart; Hiep T Doan
Journal:  J Health Care Poor Underserved       Date:  2010-05

2.  Assessing the effectiveness of a Grand Rounds CME activity for health-care professionals.

Authors:  Terry Ann Glauser; P Holder Nevins; J Chad Williamson; Brian Tomlinson
Journal:  J Cancer Educ       Date:  2013-09       Impact factor: 2.037

3.  Gastrectomy case volume and textbook outcome: an analysis of the Population Registry of Esophageal and Stomach Tumours of Ontario (PRESTO).

Authors:  Jordan Levy; Vaibhav Gupta; Elmira Amirazodi; Catherine Allen-Ayodabo; Naheed Jivraj; Yunni Jeong; Laura E Davis; Alyson L Mahar; Charles De Mestral; Olli Saarela; Natalie Coburn
Journal:  Gastric Cancer       Date:  2019-11-04       Impact factor: 7.370

4.  Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology.

Authors:  Eva J A Morris; Nicola J Maughan; David Forman; Philip Quirke
Journal:  Gut       Date:  2007-05-09       Impact factor: 23.059

5.  Multicentre review of lymph node harvest in colorectal cancer: are we understaging colorectal cancer patients?

Authors:  P J Mitchell; S Ravi; B Grifftiths; F Reid; D Speake; C Midgley; N Mapstone
Journal:  Int J Colorectal Dis       Date:  2009-04-23       Impact factor: 2.571

6.  Development of community plans to enhance survivorship from colorectal cancer: community-based participatory research in rural communities.

Authors:  Eugene J Lengerich; Brenda C Kluhsman; Marcyann Bencivenga; Regina Allen; Mary Beth Miele; Elana Farace
Journal:  J Cancer Surviv       Date:  2007-09       Impact factor: 4.442

7.  The impact of audit and feedback on nodal harvest in colorectal cancer.

Authors:  Geoffrey A Porter; Robin Urquhart; Jingyu Bu; Paul Johnson; Eva Grunfeld
Journal:  BMC Cancer       Date:  2011-01-03       Impact factor: 4.430

8.  A blended knowledge translation initiative to improve colorectal cancer staging [ISRCTN56824239].

Authors:  Frances C Wright; Calvin H L Law; Linda D Last; Neil Klar; David P Ryan; Andrew J Smith
Journal:  BMC Health Serv Res       Date:  2006-01-16       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.